These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo coronary lesions. Vetrovec GW; Rizik D; Williard C; Snead D; Piotrovski V; Kopia G Catheter Cardiovasc Interv; 2006 Jan; 67(1):32-7. PubMed ID: 16342216 [TBL] [Abstract][Full Text] [Related]
24. Coronary stent fracture in a saphenous vein graft to right coronary artery--successful treatment by the novel use of the Jomed coronary stent graft: case report and review of the literature. Koh TW; Mathur A Int J Cardiol; 2007 Jul; 119(2):e43-5. PubMed ID: 17467086 [TBL] [Abstract][Full Text] [Related]
25. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
27. The final answer? For the treatment of saphenous vein graft disease, drug-eluting stents vs. bare-metal stents. Michishita I Circ J; 2011; 75(2):261-2. PubMed ID: 21228495 [No Abstract] [Full Text] [Related]
28. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions. Vermeersch P; Agostoni P Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167 [TBL] [Abstract][Full Text] [Related]
29. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents. Bansal D; Sachdeva R; Mehta JL J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169 [No Abstract] [Full Text] [Related]
30. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238 [TBL] [Abstract][Full Text] [Related]
31. Pathology of restenosis in saphenous bypass grafts after long-term stent implantation. Depre C; Havaux X; Wijns W Am J Clin Pathol; 1998 Sep; 110(3):378-84. PubMed ID: 9728614 [TBL] [Abstract][Full Text] [Related]
32. [Comparison of the effects of rapamycin-eluting stent implantation and coronary artery bypass grafting in treatment of patients with multi-vessel coronary disease]. Han YL; Wang XZ; Jing QM; Wang SL; Ma YY; Wang HS; Luan B Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2826-9. PubMed ID: 16324339 [TBL] [Abstract][Full Text] [Related]
34. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease. Zakliczynski M; Lekston A; Osuch M; Swierad M; Nadziakiewicz P; Przybylski R; Zembala M Transplant Proc; 2007 Nov; 39(9):2859-61. PubMed ID: 18022002 [TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Okabe T; Lindsay J; Buch AN; Steinberg DH; Roy P; Slottow TL; Smith K; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R Am J Cardiol; 2008 Sep; 102(5):530-4. PubMed ID: 18721507 [TBL] [Abstract][Full Text] [Related]
37. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562 [TBL] [Abstract][Full Text] [Related]
38. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis. Applegate RJ; Sacrinty M; Kutcher M; Santos R; Gandhi S; Little W Catheter Cardiovasc Interv; 2008 Jul; 72(1):7-12. PubMed ID: 18412239 [TBL] [Abstract][Full Text] [Related]